Drugmaker to study pig kidney transplants in humans with groundbreaking trial
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys for patients with end-stage renal disease. Study aims to provide alternative for 500,000 Americans on dialysis.
A Second Person Has Received a Pig Kidney Transplant
The second person ever has received a transplant with a genetically modified pig kidney.
FDA OKs clinical trials for pig kidney transplants in people
The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.
United Therapeutics scores FDA go-ahead for pig organ transplant clinical trial
Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the medical community as it is for the business.
FDA Approves Transplant Trials for Gene-Edited Pig Kidneys
Two biotechnology companies will begin testing the procedures in patients suffering from kidney failure Sarah Kuta Daily Correspondent Doctors at NYU Langone Health recently performed a transplant surgery using a gene-edited pig kidney.
Breakthrough: US FDA clears first gene-edited pig kidney transplants in humans
In a significant development for organ transplantation, two U.S. biotechnology companies, United Therapeutics and
Experimental transplants with organs from gene-edited pigs see major steps forward
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...
New Hampshire man is 2nd person known to be living with a pig kidney
His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from ...
FierceBiotech7h
eGenesis announces 2nd pig kidney procedure success, as xenotransplantation field moves forward
Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...
United Therapeutics price target lowered to $460 from $475 at UBS
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
STAT4d
FDA approves first xenotransplantation clinical trial, as United Therapeutics forges ahead
United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...
United Therapeutics president sells $3.5m in stock
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...
Forbes10d
United Therapeutics
United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic ...
United Therapeutics: TETON 1 study of nebulized Tyvaso for IPF fully enrolled
United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...
United Therapeutics president Michael Benkowitz sells shares worth $3.65m
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions involving the company's common stock. On January 21, Benkowitz sold ...